WTF?! There's been another incident further proving that buying from Amazon isn't always safe, even when the product is sold by the company itself. A customer who purchased a Corsair Vengeance DDR5 ...

Exclusive YouTube Nerf shorts! If you like this video, click like and share it with others so we make more of them! Danny grabs his Nerf Hyper Rush 40 blaster and takes out some water bottle targets ...

>80% KIT knock-down and significant tumor-volume reduction in systemic mastocytosis and GIST models; GLP-validated bio analytics complete; Japan Patent protects through 2039 as IND work advances.

Complete GLP toxicology and CMC packages; submit IND. Initiate Phase 1/2 dose-escalation/expansion study in advanced systemic mastocytosis and other KIT-driven tumors with translational biomarkers of ...

Gearbox has finally released the first major Borderlands 4 buff patch, improving all four Vault Hunters in the name of "greater build diversity." My eyes have admittedly glazed over a bit under the ...

AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) today announced the launch of capability enhancements for its Puma™ LE small unmanned aircraft system (SUAS): an integrated Laser Target Designator payload ...

With these upgrades, Puma LE evolves beyond intelligence, surveillance, and reconnaissance (ISR) to support multi-mission operations—delivering unmatched portability, modular adaptability, and ...

The new Laser Target Designator Kit transforms the Puma LE into a cutting-edge precision targeting platform while the Universal Gimbal Kit further enhances operational flexibility by allowing ...

The warning came from researchers at Las Vegas-based AI security outfit Abnormal, industry news site TechRadar reports. Over 900 organizations, mostly in the U.S., U.K., Canada, and Australia, have ...

HT-KIT triggered significant tumor cell death in preclinical models of gastrointestinal stromal tumors (GIST) and systemic mastocytosis as early as 24 hours post-treatment, with statistically ...

Celldex Therapeutics Inc. unveiled top-line data from the ongoing phase II study testing barzolvolimab (barzo) in eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus. The ...

Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company ...